May 10, 2016 — MEDraysintell announced it will display its series of market reports and directories during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) congress, June 11-15, in San Diego. The reports contain over 1,800 pages of intelligence covering nuclear medicine, cyclotrons, brachytherapy and proton therapy.
Nuclear Medicine World Market Report & Directory, Edition 2015 is a 930-page report and directory describing and analyzing over 335 radiopharmaceuticals and radionuclides, and more than 160 companies and institutions active in nuclear medicine.
Cyclotrons used in Nuclear Medicine, Edition 2015 is a 350-page report providing an extensive review of all cyclotrons around the world (over 1,200) with an exhaustive profile of the 14 companies active in this market.
The global brachytherapy industry is evaluated in a new and updated MEDraysintell report and directory, providing in a 340-page document a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.
Proton Therapy world market report, Edition 2015 is the most comprehensive evaluation of the world proton therapy industry. This report includes a complete market review and contains a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.
MEDraysintell reports and directories can be customized to specific areas or modalities. Sample pages and complete table of contents are available upon request.
For more information: www.medraysintell.com
July 30, 2024 
